• 
  C. Xhaard, A. Dumas, V. Souchard, Y. Ren, F. Borson-Chazot, et al.. Are dietary reports in a case-control study on thyroid cancer biased by risk perception of Chernobyl fallout?. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2017, 65 (4), pp.301-308. ⟨10.1016/j.respe.2017.02.002⟩. ⟨hal-04043710⟩
• 
  Thomas Raze, Brigitte Lacour, Anne Cowppli-Bony, Patricia Delafosse, Michel Velten, et al.. Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival. Journal of Adolescent and Young Adult Oncology, 2021, 10 (1), pp.29-45. ⟨10.1089/jayao.2020.0017⟩. ⟨hal-04020187⟩
• 
  Marie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier, Clelia Coutzac, Thierry Lecomte, et al.. Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer, 2023, ⟨10.1002/ijc.34414⟩. ⟨hal-03969427⟩
• 
  Elyette Broly, Philippe Barthélémy, Saïd Ciftci, Christian Borel, Martin Broly, et al.. Hidden intra-mandibular carcinoma cuniculatum appearing in a patient with metastatic prostate cancer: a case report. BMC Oral Health, 2019, 19 (1), pp.54. ⟨10.1186/s12903-019-0745-1⟩. ⟨hal-03889807⟩
• 
  Christian Borel, Olivier Regnier-Gavier, Hélène Carinato, Sébastien Guihard, Delphine Antoni, et al.. Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget, 2018, 9 (101), pp.37581-37588. ⟨10.18632/oncotarget.26506⟩. ⟨hal-03881981⟩
• 
  Clélia Coutzac, Frédéric Bibeau, Méher Ben Abdelghani, Thomas Aparicio, Romain Cohen, et al.. Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial. Digestive and Liver Disease, 2022, 54 (10), pp.1335-1341. ⟨10.1016/j.dld.2022.07.008⟩. ⟨hal-03837196⟩
• 
  Alexandre Detappe, Clélia Mathieu, Caining Jin, Michael P. Agius, Marie-Charlotte Deringer, et al.. Anti-MUC1-C Antibody–Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 2020, 108 (5), pp.1380-1389. ⟨10.1016/j.ijrobp.2020.06.069⟩. ⟨hal-03093629⟩
• 
  Waisse Waissi, Anaïs Nicol, Matthieu Jung, Marc Rousseau, Delphine Jarnet, et al.. Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation. Cancers, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩. ⟨hal-03160783⟩
• 
  Paul Cottu, Bruno Coudert, David Perol, Anne Doly, Julien Manson, et al.. Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018). European Journal of Cancer, 2020, 141, pp.209 - 217. ⟨10.1016/j.ejca.2020.10.012⟩. ⟨hal-03493774⟩
• 
  Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, Pierre Blanchard, Dana Hartl, et al.. Anaplastic Thyroid Carcinoma: An Update. Cancers, 2022, 14, ⟨10.3390/cancers14041061⟩. ⟨hal-03859894⟩
• 
  T. Aparicio, A. Darut-Jouve, F. Khemissa Akouz, C. Montérymard, P. Artru, et al.. Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD. Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩. ⟨hal-02901884⟩
• 
  Akila Saim, François Gernier, Idlir Licaj, Julien Rod, Michel Velten, et al.. Situation professionnelle à long terme après un cancer : étude réalisée à partir de registres de population. Bulletin du Cancer, 2020, 107, pp.867 - 880. ⟨10.1016/j.bulcan.2020.06.004⟩. ⟨hal-03491460⟩
• 
  Paul-Michel Mertes, Olivier Collange, Pierre Coliat, Mainak Banerjee, Marie-Charlotte Diringer, et al.. Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation. Journal of Controlled Release, 2021, 336, pp.252-261. ⟨10.1016/j.jconrel.2021.06.033⟩. ⟨hal-03767483⟩
• 
  Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Christine Lasset, et al.. Variation in breast cancer risk with mutation position smoking alcohol and chest X-ray history in the French National BRCA1/2 carrier cohort (GENEPSO). Breast Cancer Research and Treatment, 2011, 130 (3), pp.927-938. ⟨10.1007/s10549-011-1655-3⟩. ⟨hal-00698006⟩
• 
  Matthieu Frasca, Camille Sabathe, Suzette Delaloge, Angeline Galvin, Anne Patsouris, et al.. Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008–2016. European Journal of Cancer, 2020, 137, pp.240-249. ⟨10.1016/j.ejca.2020.07.007⟩. ⟨hal-02995511⟩
• 
  L. Kuntz, R. Matthis, N. Wegner, S. Lutz. Dosimetric comparison of mono-isocentric and multi-isocentric plans for oligobrain metastases: A single institutional experience. Cancer/Radiothérapie, 2020, 24, pp.53 - 59. ⟨10.1016/j.canrad.2019.10.003⟩. ⟨hal-03489946⟩
• 
  P. Gougis, M. Carton, C. Tchokothe, M. Campone, F. Dalenc, et al.. CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database. The Breast, 2020, 49, pp.17-24. ⟨10.1016/j.breast.2019.10.004⟩. ⟨hal-02888468⟩
• 
  Christophe Borg, Georges Mantion, Frank Boudghène, Françoise Mornex, François Ghiringhelli, et al.. Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study. Clinical Colorectal Cancer, 2019, 18, pp.200 - 208.e1. ⟨10.1016/j.clcc.2019.04.006⟩. ⟨hal-03487688⟩
• 
  Flora Nguyen van Long, Audrey Lardy-Cleaud, Dimitri Carène, Caroline Rossoni, Frédéric Catez, et al.. Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer. BMC Cancer, 2022, 22 (1), pp.526. ⟨10.1186/s12885-022-09552-x⟩. ⟨inserm-03690923⟩
• 
  Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, et al.. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast, 2020, 52, pp.50-57. ⟨10.1016/j.breast.2020.04.009⟩. ⟨hal-02888009v2⟩

80

118